ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PBI vs TMO // 10Y YIELD & FRED MACRO BETA

Pitney Bowes Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PBI 3 — TMO 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PBI VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PBI TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 9.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield 14.05% 2.40% +11.65 PBI /fcf-yield <GO>
Operating Margin — 17.40% — TIE /operating-margins <GO>
Net Profit Margin 7.60% 15.10% -7.50 TMO /net-margins <GO>
Revenue Growth (YoY) -6.60% 3.90% -10.50 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.26% 0.24% +2.02 PBI /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.2 62.9 -23.68 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 14.5x 36.3x -21.80 PBI /forward-pe <GO>
Enterprise Scale & Market Cap $2.26B $262.22B -$259.96B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PBI REV TMO REV PBI GROSS % TMO GROSS % PBI FCF TMO FCF
FY 2025 $1.89B $44.56B — — $317.0M $6.29B
FY 2024 $2.03B $42.88B 52.4% — $156.8M $7.27B
FY 2023 $2.08B $42.86B — — $80.1M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PBI // BETA —
TMO // BETA 0.94